Form D Explorer

Inspect source fieldsReport a record issue

Form D — Akari Therapeutics Plc

0001493152-26-027117 · filed Jun 3, 2026

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Other Health Care filings

Offering

Industry
Other Health Care
Exemptions
06b
Reported offering amount
$5,500,000
Reported amount sold
$1,833,333
Minimum investment
$0
Investors
6
Sales commission
$125,000
Finders' fees
$0

Issuer

Name
Akari Therapeutics Plc
CIK
1541157
Entity
Other
Jurisdiction
UNITED KINGDOM
Year incorporated
—
Address
401 EAST JACKSON STREET
TAMPA, FL 33602
Phone
(929) 274-7510

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Other filings from this issuer

View the original filing on SEC EDGAR ↗